The purpose of this study is to formally follow up and record the safety and effectiveness of autologous (your own) stem cell injections in the treatment of knee arthritis. A secondary objective is to determine whether stem cell therapy offers disease modifying potential and therefore whether it can limit, prevent or possibly reverse progression of arthritis. This study is currently open for recruitment but at this stage entry into the study is patient funded.

Key inclusion criteria

1. Radiological diagnosis of arthritis using the American College of Rheumatology criteria

2. Primary arthritis treatment already undertaken. Autologous MSC is an invasive treatment and guidelines recommend trialling conservative measures as the first line of treatment in osteoarthritis

3. Sufficient English skills to complete the questionnaires required for the study, as well as to understand the instructions given by the study doctors.

4. Be 18 years of age or older.

 Key exclusion criteria

1. Age <18yrs.

2. Pregnancy or Breastfeeding.

3. Have other causes of their symptoms suspected to be due to serious pathology such as tumour or referral from the spine. These conditions are not under investigation within the current project.

4. Current cancer.

5. History of significant organ impairment/failure.

6. History of allergy to any substances used within the treatments.

7. Bovine allergy

The purpose of this study is to formally follow up and record the safety and effectiveness of autologous (your own) stem cell injections in the treatment of hip arthritis. A secondary objective is to determine whether stem cell therapy offers disease modifying potential and therefore whether it can limit, prevent or possibly reverse progression of arthritis. This study is currently open for recruitment but at this stage entry into the study is patient funded.

Key inclusion criteria

1. Radiological diagnosis of arthritis using the American College of Rheumatology criteria

2. Primary arthritis treatment already undertaken. Autologous MSC is an invasive treatment and guidelines recommend trialling conservative measures as the first line of treatment in osteoarthritis

3. Sufficient English skills to complete the questionnaires required for the study, as well as to understand the instructions given by the study doctors.

4. Be 18 years of age or older.

 Key exclusion criteria

1. Age <18yrs.

2. Pregnancy or Breastfeeding.

3. Have other causes of their symptoms suspected to be due to serious pathology such as tumour or referral from the spine. These conditions are not under investigation within the current project.

4. Current cancer.

5. History of significant organ impairment/failure.

6. History of allergy to any substances used within the treatments.

7. Bovine allergy

 The purpose of this study is to formally follow up and record the safety and effectiveness of autologous (your own) stem cell injections in the treatment of joints in the foot and anlke that have arthritis. A secondary objective is to determine whether stem cell therapy offers disease modifying potential and therefore whether it can limit, prevent or possibly reverse progression of arthritis. This study is currently open for recruitment but at this stage entry into the study is patient funded.

Key inclusion criteria

1. Radiological diagnosis of arthritis using the American College of Rheumatology criteria

2. Primary arthritis treatment already undertaken. Autologous MSC is an invasive treatment and guidelines recommend trialling conservative measures as the first line of treatment in osteoarthritis

3. Sufficient English skills to complete the questionnaires required for the study, as well as to understand the instructions given by the study doctors.

4. Be 18 years of age or older.

 Key exclusion criteria

1. Age <18yrs.

2. Pregnancy or Breastfeeding.

3. Have other causes of their symptoms suspected to be due to serious pathology such as tumour or referral from the spine. These conditions are not under investigation within the current project.

4. Current cancer.

5. History of significant organ impairment/failure.

6. History of allergy to any substances used within the treatments.

7. Bovine allergy

The purpose of this study is to formally follow up and record the safety and effectiveness of autologous (your own) stem cell injections in the treatment of upper limb arthritis. A secondary objective is to determine whether stem cell therapy offers disease modifying potential and therefore whether it can limit, prevent or possibly reverse progression of arthritis. This study is currently open for recruitment but at this stage entry into the study is patient funded.

Key inclusion criteria

1. Radiological diagnosis of arthritis using the American College of Rheumatology criteria

2. Primary arthritis treatment already undertaken. Autologous MSC is an invasive treatment and guidelines recommend trialling conservative measures as the first line of treatment in osteoarthritis

3. Sufficient English skills to complete the questionnaires required for the study, as well as to understand the instructions given by the study doctors.

4. Be 18 years of age or older.

 Key exclusion criteria

1. Age <18yrs.

2. Pregnancy or Breastfeeding.

3. Have other causes of their symptoms suspected to be due to serious pathology such as tumour or referral from the spine. These conditions are not under investigation within the current project.

4. Current cancer.

5. History of significant organ impairment/failure.

6. History of allergy to any substances used within the treatments.

7. Bovine allergy